Da der er risiko for en stigning i dosis - relaterede bivirkninger, kan det være nødvendigt at reducere dosis af rosiglitazon.
Since there is a potential for an increase in the risk of dose-related adverse reactions, a decrease in rosiglitazone dose may be needed.